depression

9511213674_31a3c06cc7_z

Introduction

Clinical, unipolar depression is more than just feeling low for a day or two.

Depression is characterised as episodes of sadness, loss of interest and pleasure, often including feelings of low self-worth. Depression can also include a range of physiological symptoms, such as fatigue, pain, diminished appetite, lack of interest in sex, disturbed sleep, and poor concentration.

The World Health Organisation estimates that, globally, as many as 350 million people are affected at any given time, with one person in 20 reporting an episode of depression in a 12 month period (in a global sample of 17 countries). They describe depression as the leading cause of disability worldwide.

What we know already

We know that, despite the considerable global burden of depression, not everybody receives treatment, with figures ranging from 50% to 10% in less developed countries.

Evidence suggests that combined psychological and pharmacological treatments seem to work well. Broadly, we know that psychotherapies work in many cases – but not every time. We know that neurochemical factors, such as serotonergic dysfunction, play an important role in depression, which goes a long way in explaining the efficacy of SSRI treatments.

We also know that depression has a nasty habit of recurrence, and some psychological interventions, such as Mindfulness-Based Cognitive Therapy (MBCT) is recommended particularly for people who have experienced multiple episodes of depression, but not are currently severely depressed.

We know that people living with chronic physical illness are more likely to experience depression, and this combination is linked with poorer clinical outcomes.

Importantly though, we know that people with depression can still enjoy themselves, and a common misconception in depression is that people feel totally awful all of the time.

Areas of uncertainty

There is much still to determine. For example, we know that depression is hereditable, however the extent of heredity versus environmental influences are unclear.

We are also unsure as to the precise mechanisms that determine those who respond best to treatments, be they psychopharmacological, or psychological, or both.

What’s in the pipeline?

Despite advances in our understanding of depression, and how it is treated, it remains a highly recurrent difficulty, with many people not achieving complete remission between episodes.

Preventative interventions, either physiological, or psychological, may improve people’s resilience to depression, particularly those identified as being highly prone.

References

Cuijpers, P. (2015). Psychotherapies for adult depression: recent developments. Current Opinion in Psychiatry, 28, 24-29. [Abstract]

Naylor, C., Parsonage, M., McDaid, D., Knapp, M., Fossey, M. and Galea, A. (2012) Long-term conditions and mental health: the cost of co-morbidities. The King’s Fund, London, UK [PDF]

World Health Organisation (2015).Factsheet 369: Depression [Link]

Photo Credits

Sascha Kohlmann CC BY 2.0

Acknowledgement

Written by: Patrick Kennedy-Williams
Reviewed by:
Last updated: Nov 2015
Review due: Sep 2016

Our depression Blogs

Loneliness in Canada during the COVID-19 pandemic: All the lonely people, where [in Canada] do they all come from?

Featured

Heather McClelland reviews a recent study which explores who is most likely to experience loneliness in Canada during the COVID-19 pandemic.

[read the full story...]

Loneliness linked to mid-life depression: can tackling loneliness help prevent depression in older people?

alma-pPiZALnusz0-unsplash

A group of students from the UCL MSc in Mental Health Studies summarise a study on the association between loneliness and depression among older adults.

[read the full story...]

Antidepressant discontinuation and continuation: new Cochrane review finds miasma of confound

Depression.,Antidepressants.,Young,Character,Trapped,In,A,Pill,Bottle.,Capsules.

Adele Framer, Founder of SurvivingAntidepressants.org, explores a recent Cochrane review on antidepressant discontinuation versus continuation for adults with depression or anxiety, which highlights huge uncertainty in the science about antidepressant withdrawal.

[read the full story...]

Mental health difficulties commonly reported by ICU staff during the pandemic

vladimir-fedotov-YLmPK-XA1cM-unsplash

Nada Seif reviews a recent survey study on self-reported mental health problems in ICU staff working during the UK 2020 COVID-19 pandemic.

[read the full story...]

Living in anxious times? The rise of anxiety disorders in the UK

Close,Up,Frustrated,Thoughtful,Young,Woman,Thinking,About,Problems,,Sitting

Alice Grishkov and Derek Tracy explore a recent paper, which finds that generalised anxiety disorder is on the rise in the UK, especially in young women.

[read the full story...]

Transcranial direct current stimulation (tDCS) for unipolar and bipolar depression

Brain,Stimulation,,Conceptual,Image.,Brain,And,Electrodes.

Delia Ciobotaru reviews a recent randomised controlled trial on the neurocognitive effects of transcranial direct current stimulation in depression.

[read the full story...]

Are apps for depression and anxiety worth the money?

Featured

Andres Fonseca summarises a recent RCT which finds that apps for depression and anxiety in an IAPT service can be effective and cost effective.

[read the full story...]

Playing on uneven playing fields: low income, parental stress and maternal depression

shutterstock_1116678368

Aggelos Stamos reviews a cross-sectional Canadian study that explores the links between low socioeconomic status, parental stress, maternal depression, and the mediating role of social capital in mothers.

[read the full story...]

Inflammation and depression in young people #ActiveIngredientsMH

maria-clara-araruna-Y1QdOLp65AY-unsplash

Yara Toenders and Lianne Schmaal consider the links between inflammatory dysregulation and depression in young people, by reviewing a recent study carried out by researchers in the US, and also by presenting the results of their own recent #ActiveIngredientsMH review, which was funded by the Wellcome Trust.

[read the full story...]

Mental health apps: using implementation science to understand sustained use

Featured

Bethany Gill summarises a recent narrative review of mental health apps for depression and anxiety, which explores what’s needed to make sure apps are successfully implemented and used sustainably.

[read the full story...]